Multiple Causes of Cardiotoxic Effects in Patients With Chronic Myeloid Leukemia-Reply

JAMA Oncol. 2016 Jun 1;2(6):829. doi: 10.1001/jamaoncol.2016.1011.

Authors

Jonathan Douxfils¹, Hélène Haguet¹, Jean-Michel Dogné¹

Affiliation

¹ Department of Pharmacy, Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.

PMID: 27281625
DOI: 10.1001/jamaoncol.2016.1011

No abstract available

MeSH terms

Cardiotoxicity / etiology
Cardiotoxicity / pathology
Cardiovascular Abnormalities / chemically induced
Cardiovascular Abnormalities / physiopathology*
Humans
Imatinib Mesylate / adverse effects*
Imatinib Mesylate / therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology

Substances

Imatinib Mesylate